Skip to main content

Carbamazepine

NDC 50268-172 · AvPAK

Generic nameCarbamazepine
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength300 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryANDA

Packages

50268-172-13 — 30 BLISTER PACK in 1 BOX (50268-172-13) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (50268-172-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43353-953 — CARBAMAZEPINE, 46708-420 — Carbamazepine, 46708-421 — Carbamazepine, 46708-422 — Carbamazepine, 46708-731 — CARBAMAZEPINE, 50090-0384 — Carbamazepine, 50090-5740 — Carbamazepine, 50268-160 — CARBAMAZEPINE, 50268-170 — Carbamazepine, 50268-171 — Carbamazepine, 50742-257 — carbamazepine, 50742-258 — carbamazepine, 50742-259 — carbamazepine, 51407-215 — Carbamazepine, 51407-895 — Carbamazepine, 51407-896 — Carbamazepine, 51407-897 — Carbamazepine, 51672-4005 — Carbamazepine, 51672-4041 — Carbamazepine, 51672-4047 — Carbamazepine, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.